comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 22:47:25 - browse：2373

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： RaDonda Vaught case: a double standard for nurses, physicians

Wikipedia

WSS

Galapagos to make CAR

Make 'food is medicine' a key part of White House nutrition meeting

7 people shot in DC, police say

Cherokee Nation medical school graduates its first class

Galapagos to make CAR

As H5N1 spreads in cows, experts warn against drinking raw milk

knowledge

comprehensive

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bacterial infection may be ‘key event’ in endometriosis, study says

Supreme Court strikes down use of affirmative action

Doctor appointment wait times are getting worse

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Can food be medicine? And other questions about a new push

Sports medicine is finally prioritizing gender equality

Free medical tuition alone isn't enough to close gaps in primary care

Trump demands the U.S. pay no more for drugs than other countries … again

Can food be medicine? And other questions about a new push

focus

Galapagos to make CAR

Abbott's new stent may help patients with peripheral artery disease

ALS treatment from Biogen, Ionis fails in study

WuXi Biologics execs register to lobby as Congress comes for the company

Boston hospital trains restaurant workers on naloxone for overdoses

Pfizer's Covid pill remains 89% effective in final analysis, company says

Wikipedia

focus

knowledge

explore